Rapid remission of Stevens‐Johnson syndrome by combination therapy using etanercept and intravenous immunoglobulin and a review of the literature

Abstract

SJS/TEN are spectrum of rare, acute and life‐threatening delayed‐type drug hypersensitivity reactions that are associated with high mortality rates. However, no therapeutic standard has been proposed for SJS/TEN. Here, we report a case of a patient diagnosed with Stevens‐Johnson syndrome whose disease progression was halted by a single dose of etanercept and was treated successfully. In addition, we reviewed the literature reporting patients with SJS/TEN treated with similar regimens.

This article is protected by copyright. All rights reserved.

http://bit.ly/2FPr2a7